Pharmacokinetics and renal function after conversion from standard to microemulsion formulation of cyclosporine in stable renal transplant patients.
Department of Transplant Immunology and Innovative Antirejection Therapies, Ospedali Riuniti di Bergamo, Mario Negri Institute for Pharmacological Résearch, Italy.
F
F
Gaspari
M F
MF
Anedda
O
O
Signorini
S C
SC
Amuchastegui
N
N
Perico
G
G
Remuzzi
D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D004304:Dosage Forms; D004359:Drug Therapy, Combination; D004655:Emulsions; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D007677:Kidney Function Tests; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D012079:Renal Circulation / Q000187:drug effects; D013256:Steroids / Q000627:therapeutic use
D004304:Dosage Forms; D004655:Emulsions; D007166:Immunosuppressive Agents; D013256:Steroids; D016572:Cyclosporine; D001379:Azathioprine